MYHEALTH PHARMACY LTD


Directors	JAWAD, Ali
	JAWAD, Husam


Registered Address	Unit G04 10 Courtenay Road,
	East Lane
	Wembley
	HA9 7ND


Registered Number	12959767 (England and Wales)

Balance Sheet as at
31 December 2024

	Notes	2024		2023
		£	£	£	£
Fixed assets
Intangible assets	3		566,667		646,667
Tangible assets	4		92,808		122,965
			659,475		769,632
Current assets
Debtors	5	295,192		405,967
Cash at bank and on hand		51,563		38,951
		346,755		444,918
Creditors amounts falling due within one year	6	(613,128)		(813,528)
Net current assets (liabilities)			(266,373)		(368,610)
Total assets less current liabilities			393,102		401,022
Creditors amounts falling due after one year	7		(444,052)		(512,051)
Net assets			(50,950)		(111,029)
Capital and reserves
Called up share capital			100		100
Profit and loss account			(51,050)		(111,129)
Shareholders' funds			(50,950)		(111,029)

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 29 September 2025, and are signed on its behalf by:

JAWAD, Ali
Director

JAWAD, Husam
Director

Registered Company No. 12959767

MYHEALTH PHARMACY LTD

Notes to the Financial Statements
for the year ended 31 December 2024

1.	Accounting policies

	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

	Statement of compliance
	The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

	Going concern
	After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.

	Turnover policy
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

	Revenue from sale of goods
	Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

Revenue from sale of goods

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Employee benefits
	Contributions to defined contribution plans are expensed in the period to which they relate.

	Foreign currency translation
	Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

Foreign currency translation

Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

	Current taxation
	Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

	Intangible assets
	Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. Goodwill is being amortised evenly over their estimated useful life of 10 years.

	Tangible fixed assets and depreciation
	Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:


		Reducing balance (%)
	Plant and machinery	25
	Fixtures and fittings	25

2.	Average number of employees


		2024		2023
	Average number of employees during the year	9		7

3.	Intangible assets

	Goodwill	Total
	£	£
Cost or valuation
At 01 January 24	800,000	800,000
At 31 December 24	800,000	800,000
Amortisation and impairment
At 01 January 24	153,333	153,333
Charge for year	80,000	80,000
At 31 December 24	233,333	233,333
Net book value
At 31 December 24	566,667	566,667
At 31 December 23	646,667	646,667

4.	Tangible fixed assets

	Land & buildings	Plant & machinery	Fixtures & fittings	Office Equipment	Total
	£	£	£	£	£
Cost or valuation
At 01 January 24	2,336	-	200,000	9,600	211,936
At 31 December 24	2,336	-	200,000	9,600	211,936
Depreciation and impairment
At 01 January 24	-	-	84,896	4,075	88,971
Charge for year	-	30,157	-	-	30,157
At 31 December 24	-	30,157	84,896	4,075	119,128
Net book value
At 31 December 24	2,336	(30,157)	115,104	5,525	92,808
At 31 December 23	2,336	-	115,104	5,525	122,965

5.	Debtors: amounts due within one year

	2024	2023
	£	£
Trade debtors / trade receivables	215,414	355,604
Amounts owed by group undertakings	1,193	1,193
Other debtors	65,627	35,547
Prepayments and accrued income	12,958	13,623
Total	295,192	405,967

6.	Creditors: amounts due within one year

	2024	2023
	£	£
Trade creditors / trade payables	83,447	82,457
Bank borrowings and overdrafts	102,065	91,991
Amounts owed to related parties	257,036	277,036
Taxation and social security	797	6,058
Other creditors	169,533	355,735
Accrued liabilities and deferred income	250	251
Total	613,128	813,528


	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

7.	Creditors: amounts due after one year

	2024	2023
	£	£
Bank borrowings and overdrafts	444,052	512,051
Total	444,052	512,051

8.	Directors advances, credits and guarantees
	Director loan account has credit balance at the year end is £8,171 (2023 £5,471)

9.	Related party transactions
	Amounts owed by group undertakings includes: £1,193 (2023: £1,193) related to Issam Group Ltd and £3,750 (2023: £3,750) related to Bropharma Holdings Limited. Amounts owed to related parties includes: £103,849 (2023: £298,205) related to Daya Ltd; £116,779 (2023: £111,336) related to Greystone Ltd, £140,699 (2023: £165,700) related to Pharmaelite Ltd.